Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy is a research paper published in Journal of Inherited Metabolic Disease (2010). On theSindex it has a DataRank of 2.2. It has been cited 45 times, with 39 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
1.6
From 38 citing papers with measurable signal
NIDDK NIH HHS
Grant: R01 DK055823
NIDDK NIH HHS
Grant: R01 DK036729
FWCI
2.41
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals